Bain uses cookies to improve functionality and performance of this site. More information can be found in our Privacy Policy. By continuing to browse this site, you consent to the use of cookies.

Snap Chart

Healthcare Corporations Lean More on M&A to Boost Revenues

Revenue growth has edged out price-to-earnings multiple expansion as the largest source of total shareholder return.

  • May 21, 2019

Snap Chart

Healthcare Corporations Lean More on M&A to Boost Revenues

The disclosed value of healthcare corporate M&A grew 31% in 2018 to an all-time high of $435 billion, partly on the back of two megamergers that accounted for about one-third of total value. As price-to-earnings multiple expansion slows and pressure against rising healthcare prices intensifies, we expect public healthcare companies to lean more on acquisitions to grow revenues. Our analysis of total shareholder return for public healthcare companies finds that revenue growth has been the single biggest driver of TSR over the past five-, three- and one-year periods ending in 2018. To maximize the value of M&A in this high-valuation environment, companies will need to craft an airtight integration thesis.

Nirad Jain and Kara Murphy are partners with Bain & Company and coleaders of the firm’s Healthcare Private Equity team.

Related Report

Corporate M&A: Healthcare Acquisitions Feed Revenue Growth

To maximize value, companies need an airtight integration thesis.


Ready to talk?

We work with ambitious leaders who want to define the future, not hide from it. Together, we achieve extraordinary outcomes.